Business ❯ Healthcare ❯ Pharmaceuticals

Manufacturing

Eli Lilly Radioligand Therapy Peptide Manufacturing AstraZeneca Expansion Facility Development Safety Investment Sterile Pharmaceuticals Rubicon Research Innovation CSL Limited Data Security Food-Grade Iron Phosphate Cell and Gene Therapy Company Investments Biologics Manufacturing Facilities Nutraceuticals Excipients Sterile Liquid Products Takeovers Novo Nordisk AbbVie Anlon Healthcare Ltd. Active Pharmaceutical Ingredients Cold Chain Storage Cell Therapy Product Distribution SteriPort and SVP Drug Delivery Systems Syringe Production

AbbVie to Build $1.4 Billion Injectable-Medicines Campus in Durham, N.C.

Performance-based incentives make public support contingent on verified hiring.

Novo Nordisk Invests €432 Million to Expand Athlone Plant for Oral GLP-1 Tablets

Novartis to Build 46,000‑Square‑Foot Radioligand Therapy Plant in Denton, Texas

Johnson & Johnson to Build $1 Billion Cell Therapy Plant in Pennsylvania

Eli Lilly Chooses Pennsylvania for $3.5 Billion Plant to Produce Weight-Loss Injectables

Eli Lilly Picks Lehigh Valley for $3.5 Billion Plant to Make Next-Gen Weight-Loss Drugs

BD Invests $110 Million to Launch Neopak Syringe Production in Nebraska

AstraZeneca Invests $2 Billion to Expand Maryland Biologics and Build New Clinical Site

Novartis Opens Carlsbad Radioligand Therapy Plant as U.S. Buildout Accelerates

Cencora Commits Over $1 Billion to U.S. Drug Distribution Buildout Through 2030

Eli Lilly Unveils $3 Billion Netherlands Plant to Scale Production of Oral Weight‑Loss Pill